Skip to main content

NEKTAR THERAPEUTICS insider trading

NKTRNASDAQ
$43.58-3.41 (-7.26%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-28.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • HWHoward W. RobinPresident & CEO0.1601%of company
  • RSR. Scott GreerDirector0.0651%of company
  • MAMark Andrew WilsonChief Legal Officer0.0632%of company
  • RARoy A. WhitfieldDirector0.062%of company
  • RCRobert ChessDirector0.0569%of company
  • JZJonathan ZalevskyChief R&D Officer0.028%of company
  • JRJeffrey Robert AjerDirector0.0125%of company
  • DBDiana BrainardDirector0.0114%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$13.4K-1.9%$71.98$13.4KAug 18, 2026Aug 20, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$30.1K-0.8%$71.98$30.1KAug 18, 2026Aug 20, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$398K-36.8%$70.00$398KJun 30, 2026Jul 2, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$277K-7.6%$61.65$277KJun 17, 2026Jun 18, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$334K-8.5%$60.81$334KJun 17, 2026Jun 18, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$285K-6.7%$60.71$285KJun 16, 2026Jun 18, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$318K-7.1%$59.97$318KJun 16, 2026Jun 18, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$336K-26.4%$60.71$336KJun 15, 2026Jun 17, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$13K-0.9%$65.51$13KMay 19, 2026May 21, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$29.1K-0.6%$65.51$29.1KMay 19, 2026May 21, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$13.1K-0.8%$73.00$13.1KFeb 18, 2026Feb 20, 2026
NKTRHoward W. RobinPresident & CEOOpen market sell$30.9K-0.6%$73.00$30.9KFeb 18, 2026Feb 20, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$138K-15.3%$35.67$138KJan 20, 2026Jan 22, 2026
NKTRJonathan ZalevskyChief R&D OfficerOpen market sell$62.8K-5.8%$54.28$62.8KNov 25, 2025Nov 25, 2025
NKTRMark Andrew WilsonChief Legal OfficerOpen market sell$34.2K-2.8%$54.28$34.2KNov 25, 2025Nov 25, 2025
NKTRHoward W. RobinPresident & CEOOpen market sell$120K-3.9%$54.28$120KNov 25, 2025Nov 25, 2025
End of history · 16 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.